Scientists are hoping to prove that type 1 diabetes can be reversed with the help of a generic drug. The five-year long, phase II clinical trial, which received approval from the U.S. Food and Drug Administration, was recently announced. Denise Faustman, associate professor of medicine at Massachusetts General Hospital, is principal investigator of the study.
Trending News
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
Harvard, Yale Researchers Awarded $46 Million Grant To Study Autism, Brain Development
Leads include stem cell biologist Paola Arlotta, biomedical AI researcher Marinka Zitnik
Mammalian Genes Can Combine To Make Previously Unknown mRNAs, Proteins
Chimeric mRNA could provide new insight into difficult-to-treat diseases